Your browser does not support JavaScript!
Logo de FierceBiotech

FierceBiotech Source d'actualité

Une actualité de FierceBiotech a été ajouté(e)
Hier à 19:48

How worms revealed a key protein in insulin synthesis and diabetes

Il y a 2 jours
By studying the nematode Caenorhabditis elegans, scientists from Vanderbilt University and the University of Michigan have identified a protein that's key for insulin synthesis, the understanding...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 15:43

Spatial tissue analysis developer Akoya nets $50M in funding

Il y a 2 jours
Akoya Biosciences, developers of spatial tissue and biomarker analysis hardware, has raised $50 million to help boost its commercialization and lay more in-roads into research, drug development and...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 14:05

Aurinia soars as phase 3 lupus study hits primary endpoint

Il y a 2 jours
A phase 3 trial of Aurinia Pharmaceuticals’ voclosporin in lupus nephritis has hit its primary endpoint, causing the company's share price to double. The data tee Aurinia up to file for FDA...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 11:52

Sage crushed by MOUNTAIN as phase 3 depression data fall short

Il y a 2 jours
Sage Therapeutics’ key phase 3 trial in major depressive disorder has missed its primary endpoint. The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors...
www.fiercebiotech.com
LILLY FRANCE
est cité dans une actualité de FierceBiotech
Hier à 07:36

Lilly rejigs cancer R&D—and puts Loxo team in charge

Il y a 2 jours
Eli Lilly is revamping its cancer research unit, combining the oncology team at Lilly Research Laboratories with Loxo Oncology, the biotech it picked up for $8 billion in January—and putting a trio of...
www.fiercebiotech.com
Charger plus d'actualités

Informations juridiques

SIREN / SIRET USA Washington, DC

Adresse

Washington DC USA- Washington, DC Etats-Unis

Equipes

Je travaille dans cette entreprise